COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors by Augustin Boudoussier, Iban Larrouture, Pauline Henrot, Rémi Veillon, Claire Bardel, Camille Chautemps, Charline Caumont, Pierre Schilfarth, Michael Duruisseaux, Maeva Zysman

Get full text